1. Biochemical and biophysical studies of Trypanosoma cruzi phosphofructokinase as a target against Chagas disease. (25th February 2016) Authors: Fernandes, Peter M; Kinkead, James; McNae, Iain; Michels, Paul; Walkinshaw, Malcolm Journal: Lancet Issue: Volume 387(2016)Supplement 1 Page Start: S43 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Biochemical and transcript level differences between the three human phosphofructokinases show optimisation of each isoform for specific metabolic niches. Issue 22 (27th November 2020) Authors: Fernandes, Peter M.; Kinkead, James; McNae, Iain; Michels, Paul A.M.; Walkinshaw, Malcolm D. Journal: Biochemical journal Issue: Volume 477:Issue 22(2020) Page Start: 4425 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Effect of ligands and redox state on phosphofructokinase quaternary structure and enzymatic activity. (23rd February 2017) Authors: Fernandes, Peter; Yen, Li-Hsuan; Kinkead, James; McNae, Iain; Michels, Paul; Walkinshaw, Malcolm Journal: Lancet Issue: Volume 389(2017)Supplement 1 Page Start: S36 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Pushing the Limits of Detection of Weak Binding Using Fragment-Based Drug Discovery: Identification of New Cyclophilin Binders. Issue 16 (4th August 2017) Authors: Georgiou, Charis; McNae, Iain; Wear, Martin; Ioannidis, Harris; Michel, Julien; Walkinshaw, Malcolm Journal: Journal of molecular biology Issue: Volume 429:Issue 16(2017) Page Start: 2556 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗